Figure 4
Figure 4. Inhibition of fibrinogen binding to αIIbβ3 reduces IAC-1 binding to α2β1 on CVX-stimulated platelets in plasma. (A) Flow cytometric experiments with FITC-labeled IAC-1, FITC-labeled monomeric collagen, and PE-labeled anti–P-selectin, binding to resting platelets (□) or to CVX-stimulated platelets in the absence (▪) or presence (⊡) of 1 μg/mL aggrastat. Data are expressed as the mean ± SEM of at least 3 independent experiments. (B) Representative tracings of the experiments depicted in panel A with the binding of FITC-labeled IAC-1 (left panel) and PE-labeled anti–P-selectin (right panel) to resting platelets (⊡) or to CVX-stimulated platelets in the absence (black line) or presence (gray line) of aggrastat. In all experiments, saturating concentrations of fluorescent antibodies were used.

Inhibition of fibrinogen binding to αIIbβ3 reduces IAC-1 binding to α2β1 on CVX-stimulated platelets in plasma. (A) Flow cytometric experiments with FITC-labeled IAC-1, FITC-labeled monomeric collagen, and PE-labeled anti–P-selectin, binding to resting platelets (□) or to CVX-stimulated platelets in the absence (▪) or presence (⊡) of 1 μg/mL aggrastat. Data are expressed as the mean ± SEM of at least 3 independent experiments. (B) Representative tracings of the experiments depicted in panel A with the binding of FITC-labeled IAC-1 (left panel) and PE-labeled anti–P-selectin (right panel) to resting platelets (⊡) or to CVX-stimulated platelets in the absence (black line) or presence (gray line) of aggrastat. In all experiments, saturating concentrations of fluorescent antibodies were used.

Close Modal

or Create an Account

Close Modal
Close Modal